Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ype P de Jong

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Cell Host & Microbe|November 16, 2018
Hepatitis C Virus Neutralizing Antibodies: Is a Vaccine Still Possible?Ype P de Jong
Seminars in Liver Disease|September 12, 2024
Mice Engrafted with Human Liver CellsYpe P de Jong
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 4, 2018
Modeling Unique Patients in Humanized Mice: Toward a Curative Strategy for HIVMarcus Dorner, Ype P de Jong
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 23, 2021
Primary human hepatocyte gene editing: Prometheus' chains are looseningEleftherios Michailidis, Ype P de Jong
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 21, 2025
Gene-based therapies for steatotic liver diseaseViktoriia Iakovleva, Ype P de Jong
Nature Biotechnology|January 29, 2025
AAV vectors tested in perfused human liversRoland W Herzog, Ype P de Jong
Journal of Viral Hepatitis|April 12, 2024
Monitoring for liver cancer post-gene therapy-How much and how often?Ype P de Jong, Ira M Jacobson
Journal of Hepatology|September 17, 2013
Antisense therapy for hepatitis C virus infectionYpe P de Jong, Ira M Jacobson
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 20, 2021
Liver gene therapy and hepatocellular carcinoma: A complex webYpe P de Jong, Roland W Herzog
Gut|May 1, 2020
Stem cell-derived HCV infection systems illustrate the bright future of human hepatocyte researchYpe P de Jong, T Jake Liang
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Cell Host & Microbe|November 16, 2018
Hepatitis C Virus Neutralizing Antibodies: Is a Vaccine Still Possible?Ype P de Jong
Seminars in Liver Disease|September 12, 2024
Mice Engrafted with Human Liver CellsYpe P de Jong
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 4, 2018
Modeling Unique Patients in Humanized Mice: Toward a Curative Strategy for HIVMarcus Dorner, Ype P de Jong
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 23, 2021
Primary human hepatocyte gene editing: Prometheus' chains are looseningEleftherios Michailidis, Ype P de Jong
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 21, 2025
Gene-based therapies for steatotic liver diseaseViktoriia Iakovleva, Ype P de Jong
Nature Biotechnology|January 29, 2025
AAV vectors tested in perfused human liversRoland W Herzog, Ype P de Jong
Journal of Viral Hepatitis|April 12, 2024
Monitoring for liver cancer post-gene therapy-How much and how often?Ype P de Jong, Ira M Jacobson
Journal of Hepatology|September 17, 2013
Antisense therapy for hepatitis C virus infectionYpe P de Jong, Ira M Jacobson
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 20, 2021
Liver gene therapy and hepatocellular carcinoma: A complex webYpe P de Jong, Roland W Herzog
Gut|May 1, 2020
Stem cell-derived HCV infection systems illustrate the bright future of human hepatocyte researchYpe P de Jong, T Jake Liang
Pageof 7